Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2018 December;60(4) > Panminerva Medica 2018 December;60(4):228-30

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

LETTERS TO THE EDITOR   

Panminerva Medica 2018 December;60(4):228-30

DOI: 10.23736/S0031-0808.18.03468-7

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Tetrahydrocannabinol: a drug of interest

Juhi TIWARI 1, Kartikey BAJPAI 2, Gaurav GUPTA 1 , Rahul SHARMA 1, Rajesh K. VERMA 1, Kamal DUA 3, 4, 5

1 School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, India; 2 MET IIT College Bandra, Mumbai, India; 3 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia; 4 School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia; 5 Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, Australia



top of page